Novartis Investigative Site

Potenza, PZ 85100

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, Psoriatic Arthritis

Studies at this site

• Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis — Completed
• Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy — Completed